BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 17257588)

  • 1. PKCepsilon is essential for gelsolin expression by histone deacetylase inhibitor apicidin in human cervix cancer cells.
    Eun DW; Ahn SH; You JS; Park JW; Lee EK; Lee HN; Kang GM; Lee JC; Choi WS; Seo DW; Han JW
    Biochem Biophys Res Commun; 2007 Mar; 354(3):769-75. PubMed ID: 17257588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histone deacetylase inhibitor apicidin downregulates DNA methyltransferase 1 expression and induces repressive histone modifications via recruitment of corepressor complex to promoter region in human cervix cancer cells.
    You JS; Kang JK; Lee EK; Lee JC; Lee SH; Jeon YJ; Koh DH; Ahn SH; Seo DW; Lee HY; Cho EJ; Han JW
    Oncogene; 2008 Feb; 27(10):1376-86. PubMed ID: 17828306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of cyclin D3 through Sp1 sites by histone deacetylase inhibitors is mediated with protein kinase C-delta (PKC-delta) signal pathway.
    Kim YH; Lim JH; Lee TJ; Park JW; Kwon TK
    J Cell Biochem; 2007 Jul; 101(4):987-95. PubMed ID: 17407153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of p21(WAF1/Cip1) through Sp1 sites by histone deacetylase inhibitor apicidin requires PI 3-kinase-PKC epsilon signaling pathway.
    Kim YK; Han JW; Woo YN; Chun JK; Yoo JY; Cho EJ; Hong S; Lee HY; Lee YW; Lee HW
    Oncogene; 2003 Sep; 22(38):6023-31. PubMed ID: 12955081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apicidin, a histone deacetylase inhibitor, inhibits proliferation of tumor cells via induction of p21WAF1/Cip1 and gelsolin.
    Han JW; Ahn SH; Park SH; Wang SY; Bae GU; Seo DW; Kwon HK; Hong S; Lee HY; Lee YW; Lee HW
    Cancer Res; 2000 Nov; 60(21):6068-74. PubMed ID: 11085529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histone deacetylase inhibitor apicidin induces cyclin E expression through Sp1 sites.
    Kim S; Kang JK; Kim YK; Seo DW; Ahn SH; Lee JC; Lee CH; You JS; Cho EJ; Lee HW; Han JW
    Biochem Biophys Res Commun; 2006 Apr; 342(4):1168-73. PubMed ID: 16516150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of NF-kappaB by HDAC inhibitor apicidin through Sp1-dependent de novo protein synthesis: its implication for resistance to apoptosis.
    Kim YK; Lee EK; Kang JK; Kim JA; You JS; Park JH; Seo DW; Hwang JW; Kim SN; Lee HY; Lee HW; Han JW
    Cell Death Differ; 2006 Dec; 13(12):2033-41. PubMed ID: 16628233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of apicidin, a histone deacetylase inhibitor, on the regulation of apoptosis in H-ras-transformed breast epithelial cells.
    Park H; Im JY; Kim J; Choi WS; Kim HS
    Int J Mol Med; 2008 Mar; 21(3):325-33. PubMed ID: 18288380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of p21(WAF1/Cip1) transcription through Sp1 sites by histone deacetylase inhibitor apicidin: involvement of protein kinase C.
    Han JW; Ahn SH; Kim YK; Bae GU; Yoon JW; Hong S; Lee HY; Lee YW; Lee HW
    J Biol Chem; 2001 Nov; 276(45):42084-90. PubMed ID: 11551946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of human gamma-globin transcriptional induction by apicidin involves p38 signaling to chromatin.
    Wei GH; Zhao GW; Song W; Hao DL; Lv X; Liu DP; Liang CC
    Biochem Biophys Res Commun; 2007 Nov; 363(4):889-94. PubMed ID: 17910885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histone deacetylase inhibitor apicidin-mediated drug resistance: involvement of P-glycoprotein.
    Kim YK; Kim NH; Hwang JW; Song YJ; Park YS; Seo DW; Lee HY; Choi WS; Han JW; Kim SN
    Biochem Biophys Res Commun; 2008 Apr; 368(4):959-64. PubMed ID: 18275843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histone deacetylase inhibitor, apicidin, inhibits human ovarian cancer cell migration via class II histone deacetylase 4 silencing.
    Ahn MY; Kang DO; Na YJ; Yoon S; Choi WS; Kang KW; Chung HY; Jung JH; Min do S; Kim HS
    Cancer Lett; 2012 Dec; 325(2):189-99. PubMed ID: 22781396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cotreatment with apicidin overcomes TRAIL resistance via inhibition of Bcr-Abl signaling pathway in K562 leukemia cells.
    Park SJ; Kim MJ; Kim HB; Sohn HY; Bae JH; Kang CD; Kim SH
    Exp Cell Res; 2009 Jul; 315(11):1809-18. PubMed ID: 19268463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of apicidin-induced cell cycle arrest and apoptosis in Ishikawa human endometrial cancer cells.
    Ahn MY; Lee J; Na YJ; Choi WS; Lee BM; Kang KW; Kim HS
    Chem Biol Interact; 2009 May; 179(2-3):169-77. PubMed ID: 19070610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of cell cycles and apoptosis by apicidin in estrogen receptor (ER)-positive and-negative human breast cancer cells.
    Im JY; Park H; Kang KW; Choi WS; Kim HS
    Chem Biol Interact; 2008 Apr; 172(3):235-44. PubMed ID: 18313654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apicidin down-regulates human papillomavirus type 16 E6 and E7 transcripts and proteins in SiHa cervical cancer cells.
    Luczak MW; Jagodzinski PP
    Cancer Lett; 2008 Dec; 272(1):53-60. PubMed ID: 18687520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apicidin is a histone deacetylase inhibitor with anti-invasive and anti-angiogenic potentials.
    Kim SH; Ahn S; Han JW; Lee HW; Lee HY; Lee YW; Kim MR; Kim KW; Kim WB; Hong S
    Biochem Biophys Res Commun; 2004 Mar; 315(4):964-70. PubMed ID: 14985106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of tumor and invasion suppressor gene modulators in bladder cancer by different classes of histone deacetylase inhibitors using reverse phase protein arrays.
    Gould JJ; Kenney PA; Rieger-Christ KM; Silva Neto B; Wszolek MF; LaVoie A; Holway AH; Spurrier B; Austin J; Cammarata BK; Canes D; Libertino JA; Summerhayes IC
    J Urol; 2010 Jun; 183(6):2395-402. PubMed ID: 20403623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differentiation of eosinophilic leukemia EoL-1 cells into eosinophils induced by histone deacetylase inhibitors.
    Ishihara K; Takahashi A; Kaneko M; Sugeno H; Hirasawa N; Hong J; Zee O; Ohuchi K
    Life Sci; 2007 Mar; 80(13):1213-20. PubMed ID: 17258775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retinoic acid and histone deacetylase inhibitor BML-210 inhibit proliferation of human cervical cancer HeLa cells.
    Borutinskaite VV; Navakauskiene R; Magnusson KE
    Ann N Y Acad Sci; 2006 Dec; 1091():346-55. PubMed ID: 17341627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.